Global and Asia Rare Disease Drug Market Status and Future Forecast 2013-2023

August 2018 | 133 pages | ID: GA070C3DFA5EN
99Strategy

Abstracts

Summary

Key Content of Chapters (Including and can be customized)

Part 1: Market Overview, Development, and Segment by Type, Application & Region
Part 2: Global Market by company, Type, Application & Region
Part 3: Asia Market by company, Type, Application & Region
Part 4-10: Key Regions of Asia Market by Type, Application
Part 11: Company information, Sales, Cost, Margin etc.
Part 12: Conclusion

Market Segment as follows:

By Region

• Global (Asia, Europe, America etc.)
• Asia (China, Southeast Asia, India, Japan, Korea, Western Asia, etc.)

Key Companies

• Novartis AG
• Bristol-Myers Squibb Company
• Celgene Corporation
• F. Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• Sanofi S.A.
• Alexion Pharmaceuticals, Inc.
• Eli Lilly and Company
• Novo Nordisk A/S
• AstraZeneca
• Eisai Co., Ltd.
• Daiichi Sankyo Company Limited
• Bayer AG
• GlaxoSmithKline
• Merck & Co., Inc.
• Johnson & Johnson
• Biogen, Inc.
• Shire
• Amgen, Inc.
• Deciphera
• Atara Biotherapeutics
• ProQR

Market by Type

• 1
• 0.65 1
• 0.1

Market by Application

• Hospital Pharmacies
• Speciality Pharmacies
• Retail pharmacies
• Others

Contents

PART 1 MARKET OVERVIEW

1.1 Market Definition
1.2 Market Development
1.3 By Type
1.4 By Application
1.5 By Region

PART 2 GLOBAL MARKET STATUS AND FUTURE FORECAST

2.1 Global Market by Region
2.2 Global Market by Company
2.3 Global Market by Type
2.4 Global Market by Application
2.5 Global Market by Forecast

PART 3 ASIA MARKET STATUS AND FUTURE FORECAST

3.1 Asia Market by Region
3.2 Asia Market by Company
3.3 Asia Market by Type
3.4 Asia Market by Application
3.5 Asia Market by Forecast

PART 4 CHINA MARKET STATUS AND FUTURE FORECAST

4.1 China Market by Type
4.2 China Market by Application
4.3 China Market by Forecast

PART 5 SOUTHEAST ASIA MARKET STATUS AND FUTURE FORECAST

5.1 Southeast Asia Market by Type
5.2 Southeast Asia Market by Application
5.3 Southeast Asia Market by Forecast

PART 6 INDIA MARKET STATUS AND FUTURE FORECAST

6.1 India Market by Type
6.2 India Market by Application
6.3 India Market by Forecast

PART 7 JAPAN MARKET STATUS AND FUTURE FORECAST

7.1 Japan Market by Type
7.2 Japan Market by Application
7.3 Japan Market by Forecast

PART 8 KOREA MARKET STATUS AND FUTURE FORECAST

8.1 Korea Market by Type
8.2 Korea Market by Application
8.3 Korea Market by Forecast

PART 9 WESTERN ASIA MARKET STATUS AND FUTURE FORECAST

9.1 Western Asia Market by Type
9.2 Western Asia Market by Application
9.3 Western Asia Market by Forecast

PART 10 OTHER REGIONS OF ASIA MARKET STATUS AND FUTURE FORECAST

10.1 Other Regions of Asia Market by Type
10.2 Other Regions of Asia Market by Application
10.3 Other Regions of Asia Market by Forecast

PART 11 KEY COMPANIES

11.1 Novartis AG
11.2 Bristol-Myers Squibb Company
11.3 Celgene Corporation
11.4 F. Hoffmann-La Roche Ltd.
11.5 Pfizer, Inc.
11.6 Sanofi S.A.
11.7 Alexion Pharmaceuticals, Inc.
11.8 Eli Lilly and Company
11.9 Novo Nordisk A/S
11.10 AstraZeneca
11.11 Eisai Co., Ltd.
11.12 Daiichi Sankyo Company Limited
11.13 Bayer AG
11.14 GlaxoSmithKline
11.15 Merck & Co., Inc.
11.16 Johnson & Johnson
11.17 Biogen, Inc.
11.18 Shire
11.19 Amgen, Inc.
11.20 Deciphera
11.21 Atara Biotherapeutics
11.22 ProQR

PART 12 CONCLUSION

List Of Tables

LIST OF TABLES

Table Type of Rare Disease Drug
Table Application of Rare Disease Drug
Table Global Rare Disease Drug Market by Region, 2013-2017 (Million USD)
Table Global Rare Disease Drug Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table Global Rare Disease Drug Market by Company, 2013-2017 (Million USD)
Table Global Rare Disease Drug Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table Global Rare Disease Drug Market by Type, 2013-2017 (Million USD)
Table Global Rare Disease Drug Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Global Rare Disease Drug Market by Application, 2013-2017 (Million USD)
Table Global Rare Disease Drug Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Asia Rare Disease Drug Market by Region, 2013-2017 (Million USD)
Table Asia Rare Disease Drug Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table Asia Rare Disease Drug Market by Company, 2013-2017 (Million USD)
Table Asia Rare Disease Drug Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table Asia Rare Disease Drug Market by Type, 2013-2017 (Million USD)
Table Asia Rare Disease Drug Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Asia Rare Disease Drug Market by Application, 2013-2017 (Million USD)
Table Asia Rare Disease Drug Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table China Rare Disease Drug Market by Type, 2013-2017 (Million USD)
Table China Rare Disease Drug Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table China Rare Disease Drug Market by Application, 2013-2017 (Million USD)
Table China Rare Disease Drug Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Southeast Asia Rare Disease Drug Market by Type, 2013-2017 (Million USD)
Table Southeast Asia Rare Disease Drug Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Southeast Asia Rare Disease Drug Market by Application, 2013-2017 (Million USD)
Table Southeast Asia Rare Disease Drug Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table India Rare Disease Drug Market by Type, 2013-2017 (Million USD)
Table India Rare Disease Drug Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table India Rare Disease Drug Market by Application, 2013-2017 (Million USD)
Table India Rare Disease Drug Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Japan Rare Disease Drug Market by Type, 2013-2017 (Million USD)
Table Japan Rare Disease Drug Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Japan Rare Disease Drug Market by Application, 2013-2017 (Million USD)
Table Japan Rare Disease Drug Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Korea Rare Disease Drug Market by Type, 2013-2017 (Million USD)
Table Korea Rare Disease Drug Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Korea Rare Disease Drug Market by Application, 2013-2017 (Million USD)
Table Korea Rare Disease Drug Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Western Asia Rare Disease Drug Market by Type, 2013-2017 (Million USD)
Table Western Asia Rare Disease Drug Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Western Asia Rare Disease Drug Market by Application, 2013-2017 (Million USD)
Table Western Asia Rare Disease Drug Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Other Regions of Asia Rare Disease Drug Market by Type, 2013-2017 (Million USD)
Table Other Regions of Asia Rare Disease Drug Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Other Regions of Asia Rare Disease Drug Market by Application, 2013-2017 (Million USD)
Table Other Regions of Asia Rare Disease Drug Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Novartis AG Information
Table Rare Disease Drug Sales, Cost, Margin of Novartis AG
Table Bristol-Myers Squibb Company Information
Table Rare Disease Drug Sales, Cost, Margin of Bristol-Myers Squibb Company
Table Celgene Corporation Information
Table Rare Disease Drug Sales, Cost, Margin of Celgene Corporation
Table F. Hoffmann-La Roche Ltd. Information
Table Rare Disease Drug Sales, Cost, Margin of F. Hoffmann-La Roche Ltd.
Table Pfizer, Inc. Information
Table Rare Disease Drug Sales, Cost, Margin of Pfizer, Inc.
Table Sanofi S.A. Information
Table Rare Disease Drug Sales, Cost, Margin of Sanofi S.A.
Table Alexion Pharmaceuticals, Inc. Information
Table Rare Disease Drug Sales, Cost, Margin of Alexion Pharmaceuticals, Inc.
Table Eli Lilly and Company Information
Table Rare Disease Drug Sales, Cost, Margin of Eli Lilly and Company
Table Novo Nordisk A/S Information
Table Rare Disease Drug Sales, Cost, Margin of Novo Nordisk A/S
Table AstraZeneca Information
Table Rare Disease Drug Sales, Cost, Margin of AstraZeneca
Table Eisai Co., Ltd. Information
Table Rare Disease Drug Sales, Cost, Margin of Eisai Co., Ltd.
Table Daiichi Sankyo Company Limited Information
Table Rare Disease Drug Sales, Cost, Margin of Daiichi Sankyo Company Limited
Table Bayer AG Information
Table Rare Disease Drug Sales, Cost, Margin of Bayer AG
Table GlaxoSmithKline Information
Table Rare Disease Drug Sales, Cost, Margin of GlaxoSmithKline
Table Merck & Co., Inc. Information
Table Rare Disease Drug Sales, Cost, Margin of Merck & Co., Inc.
Table Johnson & Johnson Information
Table Rare Disease Drug Sales, Cost, Margin of Johnson & Johnson
Table Biogen, Inc. Information
Table Rare Disease Drug Sales, Cost, Margin of Biogen, Inc.
Table Shire Information
Table Rare Disease Drug Sales, Cost, Margin of Shire
Table Amgen, Inc. Information
Table Rare Disease Drug Sales, Cost, Margin of Amgen, Inc.
Table Deciphera Information
Table Rare Disease Drug Sales, Cost, Margin of Deciphera
Table Atara Biotherapeutics Information
Table Rare Disease Drug Sales, Cost, Margin of Atara Biotherapeutics
Table ProQR Information
Table Rare Disease Drug Sales, Cost, Margin of ProQR

List Of Figures

LIST OF FIGURES

Figure Global Rare Disease Drug Market Share by Type in 2018
Figure Global Rare Disease Drug Market Share by Application in 2018
Figure Global Rare Disease Drug Market Share by Region in 2018
Figure Asia Rare Disease Drug Market Share by Region in 2018
Figure Global Rare Disease Drug Market Share by Region in 2017 (Million USD)
Figure Global Rare Disease Drug Market Share by Region in 2017 (Volume)
Figure Global Rare Disease Drug Market Share by Company in 2017 (Million USD)
Figure Global Rare Disease Drug Market Share by Company in 2017 (Volume)
Figure Global Rare Disease Drug Market Share by Type in 2017 (Million USD)
Figure Global Rare Disease Drug Market Share by Type in 2017 (Volume)
Figure Global Rare Disease Drug Market Share by Application in 2017 (Million USD)
Figure Global Rare Disease Drug Market Share by Application in 2017 (Volume)
Figure Global Rare Disease Drug Market Forecast, 2018-2023 (Million USD)
Figure Global Rare Disease Drug Market Forecast, 2018-2023 (Volume)
Figure Asia Rare Disease Drug Market Share by Region in 2017 (Million USD)
Figure Asia Rare Disease Drug Market Share by Region in 2017 (Volume)
Figure Asia Rare Disease Drug Market Share by Company in 2017 (Million USD)
Figure Asia Rare Disease Drug Market Share by Company in 2017 (Volume)
Figure Asia Rare Disease Drug Market Share by Type in 2017 (Million USD)
Figure Asia Rare Disease Drug Market Share by Type in 2017 (Volume)
Figure Asia Rare Disease Drug Market Share by Application in 2017 (Million USD)
Figure Asia Rare Disease Drug Market Share by Application in 2017 (Volume)
Figure Asia Rare Disease Drug Market Forecast, 2018-2023 (Million USD)
Figure Asia Rare Disease Drug Market Forecast, 2018-2023 (Volume)
Figure China Rare Disease Drug Market Share by Type in 2017 (Million USD)
Figure China Rare Disease Drug Market Share by Type in 2017 (Volume)
Figure China Rare Disease Drug Market Share by Application in 2017 (Million USD)
Figure China Rare Disease Drug Market Share by Application in 2017 (Volume)
Figure China Rare Disease Drug Market Forecast, 2018-2023 (Million USD)
Figure China Rare Disease Drug Market Forecast, 2018-2023 (Volume)
Figure Southeast Asia Rare Disease Drug Market Share by Type in 2017 (Million USD)
Figure Southeast Asia Rare Disease Drug Market Share by Type in 2017 (Volume)
Figure Southeast Asia Rare Disease Drug Market Share by Application in 2017 (Million USD)
Figure Southeast Asia Rare Disease Drug Market Share by Application in 2017 (Volume)
Figure Southeast Asia Rare Disease Drug Market Forecast, 2018-2023 (Million USD)
Figure Southeast Asia Rare Disease Drug Market Forecast, 2018-2023 (Volume)
Figure India Rare Disease Drug Market Share by Type in 2017 (Million USD)
Figure India Rare Disease Drug Market Share by Type in 2017 (Volume)
Figure India Rare Disease Drug Market Share by Application in 2017 (Million USD)
Figure India Rare Disease Drug Market Share by Application in 2017 (Volume)
Figure India Rare Disease Drug Market Forecast, 2018-2023 (Million USD)
Figure India Rare Disease Drug Market Forecast, 2018-2023 (Volume)
Figure Japan Rare Disease Drug Market Share by Type in 2017 (Million USD)
Figure Japan Rare Disease Drug Market Share by Type in 2017 (Volume)
Figure Japan Rare Disease Drug Market Share by Application in 2017 (Million USD)
Figure Japan Rare Disease Drug Market Share by Application in 2017 (Volume)
Figure Japan Rare Disease Drug Market Forecast, 2018-2023 (Million USD)
Figure Japan Rare Disease Drug Market Forecast, 2018-2023 (Volume)
Figure Korea Rare Disease Drug Market Share by Type in 2017 (Million USD)
Figure Korea Rare Disease Drug Market Share by Type in 2017 (Volume)
Figure Korea Rare Disease Drug Market Share by Application in 2017 (Million USD)
Figure Korea Rare Disease Drug Market Share by Application in 2017 (Volume)
Figure Korea Rare Disease Drug Market Forecast, 2018-2023 (Million USD)
Figure Korea Rare Disease Drug Market Forecast, 2018-2023 (Volume)
Figure Western Asia Rare Disease Drug Market Share by Type in 2017 (Million USD)
Figure Western Asia Rare Disease Drug Market Share by Type in 2017 (Volume)
Figure Western Asia Rare Disease Drug Market Share by Application in 2017 (Million USD)
Figure Western Asia Rare Disease Drug Market Share by Application in 2017 (Volume)
Figure Western Asia Rare Disease Drug Market Forecast, 2018-2023 (Million USD)
Figure Western Asia Rare Disease Drug Market Forecast, 2018-2023 (Volume)
Figure Other Regions of Asia Rare Disease Drug Market Share by Type in 2017 (Million USD)
Figure Other Regions of Asia Rare Disease Drug Market Share by Type in 2017 (Volume)
Figure Other Regions of Asia Rare Disease Drug Market Share by Application in 2017 (Million USD)
Figure Other Regions of Asia Rare Disease Drug Market Share by Application in 2017 (Volume)
Figure Other Regions of Asia Rare Disease Drug Market Forecast, 2018-2023 (Million USD)
Figure Other Regions of Asia Rare Disease Drug Market Forecast, 2018-2023 (Volume)